Skip to main content
The Evidence Base Webinar

WEBINAR: The DART study – a precision medicine approach to reducing treatment burden, cost and side effects – VIEW ON DEMAND

 
DBS PostAl remote immunoglobulin ReplacemenT monitoring (DART) Study Project

Dried blood spot (DBS) testing is a well-established method used for serological analysis, including infectious disease screening, autoantibody detection, and measurement of immunoglobulins. DBS samples are collected via a simple finger-prick, with blood applied to filter paper, dried, and posted to the laboratory without special transport requirements. Samples remain stable at room temperature for several days, and recent volumetric collection devices have improved analytical accuracy.

Compared with conventional venous blood sampling, DBS reduces the need for hospital visits, phlebotomy services, specialized transport, and associated costs, while improving patient convenience.

The DART study evaluated the accuracy and acceptability of DBS testing for monitoring IgG levels in patients with antibody deficiency receiving immunoglobulin replacement therapy (IgRT) across Wales. DBS results were compared with conventional blood samples over 12 months, alongside patient questionnaires assessing acceptability and potential reduction in treatment burden.


Speakers

Stephen Jolles
Consultant Clinical Immunologist & Honorary Professor
Immunodeficiency Centre for Wales and Adult SWAN Clinic, University Hospital of Wales & Noah's Ark Children's Hospital for Wales

Stephen Jolles is a Consultant Clinical Immunologist and Honorary Professor at the University Hospital of Wales. He is the Clinical Lead at the Immunodeficiency Centre of Wales and Co-Director of the Hub Immunology Diagnostic Laboratory of Wales. Dr Jolles trained in immunology and allergy and obtained his PhD on Langerhans cell migration at the National Institute for Medical Research, London. He has a particular interest in the clinical use of immunoglobulin and its mechanism of action and his research interests include the development of new therapeutic products, new screening strategies to improve the laboratory diagnosis of primary and secondary immunodeficiency and allergy, and better ways to monitor primary and secondary immunodeficiency disease and the impact of treatments.


Emily Jacob
Senior Research Officer and Clinical Scientist
Cardiff and Vale University Health Board

Emily Jacob is a Senior Research Officer and Clinical Scientist in Immunology at Cardiff and Vale University Health Board. Her work spans laboratory assay development, translational research and the application of extended genetic testing for primary immunodeficiency. She contributes to projects aimed at enhancing diagnostic pathways and patient-centered care through innovative laboratory technologies and collaborative research.


Emily Carne
Consultant Nurse Immunology & Allergy
Immunodeficiency Centre for Wales

Emily Carne is the Consultant Nurse in Immunology & Allergy Service for Wales in Cardiff. She has a particular interest in and has published on many aspects of primary immunodeficiency and allergy, including quality of life, home therapy and burden of treatment. She has been a committee member on BSI-CIAS, UKPIN, INGID, BSACI and chair of IANG. She received the first INGID award for worldwide services to Immunology in 2017 and won the RCN Wales Clinical Nurse Specialist of the Year in 2016. Her nursing team won a global patient safety day award in 2022.


Moderator 

Neil Spooner
Founder, Patient Centric Sampling Interest Group
 

Located in Hertford, UK, Neil is the Chair and co-founder of the PCSIG. He also runs a consultancy company where one of the main drivers is to help Clients understand the benefits of patient centric blood sampling, develop appropriate technologies and workflows and implement them for the benefit of human wellbeing. Neil’s interest in these technologies began in 2007 whilst leading efforts at GlaxoSmithKline to find blood sampling and analysis approaches suitable for the measurement of pharmaceutical concentrations in samples obtained from children.


Sponsor information

 

Altasciences: Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.

Alturas Analytics: Alturas Analytics provides expert GLP & non-GLP LC-MS/MS and GC-MS/MS bioanalytical and PK/TK analysis services of small and large molecules in any matrix for discovery through Phase IV clinical trials.

Ambient Biosciences

Artyc: Artyc's battery-powered cold chain packaging is purpose-built for remote microsample collection, featuring precise temperature and location monitoring to safely enable a wider range of tests (e.g., refrigerated) in remote settings.

BD: One of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

Bento Biology Platforms: A leading self-service biosampling company, transforming the decentralized clinical trial and biorepository landscape. Bento’s Biology Boxes deliver best-in-class biosampling and biosensing tools to each patient’s doorstep and guide them every step of the way with 24/7 live support, all backed by a hyper-kitting facility and sophisticated kitting logistics software. Created and vetted with participant input all along the design path, powered by game economies and participate-to-earn wallet technology, our digital symptom diaries (PROMs) and pharmacovigilance tools build trust across all medical communities while also radically reducing costs, accelerating time-to-market, and significantly lowering cost per-patient-visit.

Boehringer Ingelheim: Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products. Every day our scientists are charting new territory and continuing our commitment to innovation that has created exceptional medicines that have changed the lives of millions of patients. We embrace the power of partnership and diversity of minds across the life-science communities to realize even more innovation and incubate new ideas.”

Capitainer: Dried blood spots (DBS) is now quantitative with volumetric control through our microfluidic qDBS technology solution. Precision, accuracy, sample protection and ease of use both at sampling and in the lab are key features for us in all product development.

Celerion: A world-class bioanalytical CRO dedicated to advancing drug development through cutting-edge science and patient-focused solutions. With decades of expertise, we are at the forefront of patient-centric sampling, pushing the boundaries of sensitivity to reduce sample size while maximizing the value of every precious drop of patient blood. Our mission is to ensure that each sample contributes meaningfully to the research and development of new therapies, enabling faster and more accurate insights into drug efficacy and safety. Through innovative approaches and a commitment to excellence, we are proud to support research that brings life-changing medicines to patients worldwide.

Charles River: Charles River Laboratories are a leading drug discovery and development contract research organization providing a broad spectrum of laboratory and data science support to the clinical development industry. This includes bioanalytical chemistry, immunology, biomarker services, immunoassay, genomics, vaccine development and ADME services. With over 1000 dedicated laboratory colleagues across a global footprint and expertise in traditional and advanced modalities, Charles River Laboratories are well placed to leverage scale and scope to support Clinical programs carried out anywhere in the world.

Genentech: Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit gene.com.

GSK:We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

IQVIA Laboratories: IQVIA Laboratories is a leading drug discovery and development laboratory services organization providing innovative solutions that encompass broad central laboratory and specialty biomarker services, including genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine assays, vaccine assays, ADME and bioanalytical along with extensive offerings in antibody drug discovery, biomarker discovery, and decentralized clinical trial lab solutions. Through the Decentralized Clinical Trials group, IQVIA Laboratories is at the forefront of patient-centric sampling, offering a variety of self-collection methodologies and is validating multiple assays using micro-samples that are self-collected by study participants.

LetsGetChecked: Healthcare that meets your people where they are. We enable partners to seamlessly utilize at-home healthcare programs to reduce barriers to access for those most in need.

Neoteryx: Neoteryx, a Trajan Scientific and Medical brand, offers remote microsampling devices designed for easy, reliable, cost-effective specimen collection in the clinic or field by healthcare professionals and end-users. Our innovative tools support decentralized research, remote monitoring, and personalized medicine, enabling streamlined sample collection and lab anaysis for pharmaceutical, clinical, and research sectors. Products like the Mitra® with gold-standard VAMS® technology for biological fluid sampling and the Harpera™ Microbiopsy Punch for skin sampling provide convenient, cost-effective solutions for advancing human health.

RDi: Leveraging our expertise in data processing, technology, and automation, we are revolutionising the healthcare supply chain. Through fulfilment and traceable kitting, we’re changing the way pharmaceutical and medical companies operate and deliver as part of the medical supply chain.

RedDrop Dx: Next generation blood sampling solutions.

Resolian: Global bioanalytical and analytical sciences partner supporting drug development and multi-regional clinical trials. Resolian is a leading global Contract Research Organization providing specialized services in GxP and non-regulated bioanalysis, drug metabolism/pharmacokinetic, and GMP CMC analytical and materials science. Comprised of the former Alliance Pharma, Inc., Drug Development Solutions Ltd, and Denali Medpharma labs and powered by a team of more than 500 experts across the US, UK, Australia, and China, Resolian supports pharma and biotech companies’ programs throughout the entire drug development continuum. 

Roche: Doing now what patients need next.

SampleFacts: SampleFacts is a company that specializes in providing dried blood spot (DBS) sampling. We offer a solution that enables instant separation of blood cells and plasma from a single drop of blood. With these characteristics the product facilitates the opportunity to provide a reliable and efficient method for collecting and storing blood samples, addressing the growing demand for remote sampling and biobanking.

Streck: Established in 1971, Streck develops quality control and sample stabilization products that give clinical and research laboratories worldwide confidence in the validity of their results and help make the world safer, healthier and more productive. Streck products are manufactured in La Vista, Nebraska, and delivered to thousands of labs across the globe. 

Supera Fulfillment:

Takeda: We exist to create better health for people and a brighter future for the world. While the science and technology we advance are constantly evolving, our ambition remains. We move science forward, so we can transform more lives.

Tasso: Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time.

Unilabs York Bioanalytical Solutions is a specialist provider of bioanalytical, metabolism and biomarker services to pharmaceutical and biotech companies, supporting development of small and large molecule therapeutics from discovery through to post-marketing.

Veloxity Labs: Veloxity Labs is a CRO focused on LC-MS bioanalysis. Our company is employee owned and operated, and offers start-up times and turn-around times in days by maintaining 80% capacity.


In association with

For more info on the PCSIG, please visit www.pcsig.org and follow on LinkedIn here. 

If you are interested in partnering with The Evidence Base for future webinars, please contact [email protected].